Germany · Delayed Price · Currency is EUR MedNation AG Statistics
Total Valuation
MedNation AG has a market cap or net worth of EUR 11.23 million. The enterprise value is 19.18 million.
| Market Cap | 11.23M |
| Enterprise Value | 19.18M |
Important Dates
The next estimated earnings date is Thursday, November 19, 2026.
| Earnings Date | Nov 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MedNation AG has 2.81 million shares outstanding. The number of shares has decreased by -18.76% in one year.
| Current Share Class | 2.81M |
| Shares Outstanding | 2.81M |
| Shares Change (YoY) | -18.76% |
| Shares Change (QoQ) | -35.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 3.67.
| PE Ratio | 3.67 |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| PB Ratio | 0.70 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | 8.09 |
| P/OCF Ratio | 3.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.84, with an EV/FCF ratio of 13.82.
| EV / Earnings | 7.61 |
| EV / Sales | 0.35 |
| EV / EBITDA | 5.84 |
| EV / EBIT | 10.43 |
| EV / FCF | 13.82 |
Financial Position
The company has a current ratio of 8.51, with a Debt / Equity ratio of 0.70.
| Current Ratio | 8.51 |
| Quick Ratio | 7.79 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 3.42 |
| Debt / FCF | 8.09 |
| Interest Coverage | 3.13 |
Financial Efficiency
Return on equity (ROE) is 18.13% and return on invested capital (ROIC) is 7.39%.
| Return on Equity (ROE) | 18.13% |
| Return on Assets (ROA) | 3.04% |
| Return on Invested Capital (ROIC) | 7.39% |
| Return on Capital Employed (ROCE) | 4.86% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 65,572 |
| Profits Per Employee | 3,016 |
| Employee Count | 836 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 37.37 |
Taxes
In the past 12 months, MedNation AG has paid 242,669 in taxes.
| Income Tax | 242,669 |
| Effective Tax Rate | 8.29% |
Stock Price Statistics
The stock price has increased by +38.89% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +38.89% |
| 50-Day Moving Average | 3.98 |
| 200-Day Moving Average | 3.65 |
| Relative Strength Index (RSI) | 51.57 |
| Average Volume (20 Days) | 15 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedNation AG had revenue of EUR 54.82 million and earned 2.52 million in profits. Earnings per share was 1.09.
| Revenue | 54.82M |
| Gross Profit | 12.42M |
| Operating Income | 1.84M |
| Pretax Income | 2.93M |
| Net Income | 2.52M |
| EBITDA | 3.29M |
| EBIT | 1.84M |
| Earnings Per Share (EPS) | 1.09 |
Balance Sheet
The company has 4.54 million in cash and 11.23 million in debt, with a net cash position of -6.69 million or -2.38 per share.
| Cash & Cash Equivalents | 4.54M |
| Total Debt | 11.23M |
| Net Cash | -6.69M |
| Net Cash Per Share | -2.38 |
| Equity (Book Value) | 16.14M |
| Book Value Per Share | 5.36 |
| Working Capital | 10.15M |
Cash Flow
In the last 12 months, operating cash flow was 2.88 million and capital expenditures -1.49 million, giving a free cash flow of 1.39 million.
| Operating Cash Flow | 2.88M |
| Capital Expenditures | -1.49M |
| Depreciation & Amortization | 1.45M |
| Net Borrowing | -767,000 |
| Free Cash Flow | 1.39M |
| FCF Per Share | 0.49 |
Margins
Gross margin is 22.65%, with operating and profit margins of 3.36% and 4.60%.
| Gross Margin | 22.65% |
| Operating Margin | 3.36% |
| Pretax Margin | 5.34% |
| Profit Margin | 4.60% |
| EBITDA Margin | 5.99% |
| EBIT Margin | 3.36% |
| FCF Margin | 2.55% |
Dividends & Yields
MedNation AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 18.76% |
| Shareholder Yield | 18.76% |
| Earnings Yield | 22.45% |
| FCF Yield | 12.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 29, 1999. It was a forward split with a ratio of 10.
| Last Split Date | Jan 29, 1999 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |